Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.

Authors	J E Otka, M T Mercadante, L Scahill, J F Leckman
Journal	Journal of child and adolescent psychopharmacology (J Child Adolesc Psychopharmacol) Vol. 11 Issue 2 Pg. 203-4 ( 2001) ISSN: 1044-5463 [Print] United States
PMID	11436962 (Publication Type: Case Reports, Letter)
Chemical References	Adrenergic Uptake Inhibitors Morpholines Reboxetine
Topics	Adrenergic Uptake Inhibitors (therapeutic use) Adult Attention Deficit Disorder with Hyperactivity (drug therapy) Humans Male Morpholines (therapeutic use) Reboxetine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!